New drug access for blood sugar drops after Weight-Loss surgery
NCT ID NCT07582874
First seen May 21, 2026 · Last updated Jun 18, 2026 · Updated 5 times
Summary
This program offers avexitide to people with post-bariatric hypoglycemia (low blood sugar after gastric bypass surgery) who have completed or qualified for previous studies. The goal is to provide treatment access while monitoring safety. Participants must meet specific eligibility criteria.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST-BARIATRIC HYPOGLYCEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Diabetes and Glandular Disease Clinic
AVAILABLESan Antonio, Texas, 78229-4801, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.